# A Study to Compare Two Anti-HIV Drug Combinations

> **NCT00002447** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 146 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Ritonavir
- **DRUG:** Efavirenz
- **DRUG:** Saquinavir

## Key facts

- **NCT ID:** NCT00002447
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 146 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002447, "A Study to Compare Two Anti-HIV Drug Combinations". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00002447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*